Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. Canadian Utilities is certainly a King if you're a Canadian ...

Stop using the same login credentials everywhere. The top password managers we've tested create unique, strong passwords for each of your online accounts and alert you to potential data leaks. I ...

Alphabet isn't exactly a household name, but its main subsidiary, Google, certainly is. And there's a lot more to the business and its potential than the massive internet search operation that has a ...

Dallas Business Journal's Book of Lists provides you with more than 1,000 of the hottest area companies in their fields, by ranking. Book of Lists – Unlimited View Lists as they're published and gain ...

Louisville Business First's Book of Lists provides you with more than 1,000 of the hottest area companies in their fields, by ranking. Book of Lists – Unlimited View Lists as they're published and ...